HIGHLIGHTS
- who: J#_#x00FC et al. from the Editor: Alan Landay, Rush University, UNITED Kingdom, Bionor Immuno AS, Oslo, Norway, KLIFO, Glostrup, Denmark have published the research work: Re-boost immunizations with the peptide-based therapeutic HIV vaccine, Vacc-4x, restores geometric mean viral load set-point during treatment interruption, in the Journal: PLOS ONE | https://doi.org/10.1371/journal.pone [0210965]. January 30, 2019 of /1371/
- what: Neither study was designed to evaluate the kinetics of viral rebound, and a comparison of viral load rebound is considered inappropriate because the approaches to ART . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.